Back to Agenda
Payer Town Hall Meeting: WHO Fair Pricing
Session Chair(s)
Ad Schuurman, MBA, MSC
Head of the Business Contact Centre & International Affairs, National Health Care Institute (ZIN), Netherlands
Discussions in health care are moving from innovation and science to economics and affordability. Due to current developments in technology (many new, effective products), combined with high prices demanded by companies, the sustainability of health care systems is threatened. Expensive treatments for some patients displace effective treatments for other patients: the concept of solidarity, on which our health care systems are build, is disappearing. In this session we will explore the possibility of Fair Pricing by turning the process upside down: Can society decide the price for the products, treatments and healthcare they want access to? If so, can manufacturers deliver these products at a price the health care system is willing and able to pay?
Speaker(s)
Andrew Rintoul
Innovation, Access and Use, WHO, Switzerland
Panel Discussion
Anna Bucsics, DrMed, MD
Project Advisor, MoCA, Austria
Panel Discussion
Alexander Natz, JD
Secretary General, European Confederation of Pharmaceutical Entrepreneurs, Belgium
Panel Discussion
Simone Boselli, MA
Public Affairs Director, EURORDIS, Belgium
Panel Discussion
Have an account?
